These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 36314605)

  • 21. Efficacy of non-surgical treatments for androgenetic alopecia: a systematic review and network meta-analysis.
    Gupta AK; Mays RR; Dotzert MS; Versteeg SG; Shear NH; Piguet V
    J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2112-2125. PubMed ID: 29797431
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mesotherapy using dutasteride-containing preparation in treatment of female pattern hair loss: photographic, morphometric and ultrustructural evaluation.
    Moftah N; Moftah N; Abd-Elaziz G; Ahmed N; Hamed Y; Ghannam B; Ibrahim M
    J Eur Acad Dermatol Venereol; 2013 Jun; 27(6):686-93. PubMed ID: 22486925
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Preparation, characterization and stability study of dutasteride loaded nanoemulsion for treatment of benign prostatic hypertrophy.
    Ali MS; Alam MS; Alam N; Siddiqui MR
    Iran J Pharm Res; 2014; 13(4):1125-40. PubMed ID: 25587300
    [TBL] [Abstract][Full Text] [Related]  

  • 24. 5-Alpha reductase inhibitors in androgenetic alopecia: Shifting paradigms, current concepts, comparative efficacy, and safety.
    Dhurat R; Sharma A; Rudnicka L; Kroumpouzos G; Kassir M; Galadari H; Wollina U; Lotti T; Golubovic M; Binic I; Grabbe S; Goldust M
    Dermatol Ther; 2020 May; 33(3):e13379. PubMed ID: 32279398
    [TBL] [Abstract][Full Text] [Related]  

  • 25. 5α-Reductase inhibitors in men aged 50 years or older with androgenetic alopecia: A retrospective study.
    Kang MJ; Choi JY; Sim WY; Lew BL
    J Am Acad Dermatol; 2021 Jan; 84(1):172-173. PubMed ID: 32320771
    [No Abstract]   [Full Text] [Related]  

  • 26. Comparison of oral minoxidil, finasteride, and dutasteride for treating androgenetic alopecia.
    Gupta AK; Talukder M; Williams G
    J Dermatolog Treat; 2022 Nov; 33(7):2946-2962. PubMed ID: 35920739
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Androgenetic, diffuse and senescent alopecia in men: practical evaluation and management.
    Torres F
    Curr Probl Dermatol; 2015; 47():33-44. PubMed ID: 26370642
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Effects of dutasteride on lower urinary tract symptoms: a prospective analysis based on changes in testosterone/dihydrotestosterone levels and total prostatic volume reduction.
    Shigehara K; Miyagi T; Nakashima T; Izumi K; Kitagawa Y; Mizokami A; Koh E; Shimamura M; Namiki M
    Aging Male; 2016 Jun; 19(2):128-33. PubMed ID: 26890877
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern?
    Arias-Santiago S; Camacho-Martínez FM
    Actas Dermosifiliogr; 2016 Nov; 107(9):709-711. PubMed ID: 27436801
    [No Abstract]   [Full Text] [Related]  

  • 30. Change in Prostate Specific Antigen Concentration in Men with Prostate Specific Antigen Less than 2.5 ng/ml Taking Low Dose Finasteride or Dutasteride for Male Androgenetic Alopecia.
    Kang HW; Chae MH; Park SH; Seo SP; Kim WT; Kim YJ; Yun SJ; Lee SC; Yoon TY; Kim WJ
    J Urol; 2017 Dec; 198(6):1340-1345. PubMed ID: 28743526
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The importance of dual 5alpha-reductase inhibition in the treatment of male pattern hair loss: results of a randomized placebo-controlled study of dutasteride versus finasteride.
    Olsen EA; Hordinsky M; Whiting D; Stough D; Hobbs S; Ellis ML; Wilson T; Rittmaster RS;
    J Am Acad Dermatol; 2006 Dec; 55(6):1014-23. PubMed ID: 17110217
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adverse effects of 5α-reductase inhibitors: What do we know, don't know, and need to know?
    Traish AM; Melcangi RC; Bortolato M; Garcia-Segura LM; Zitzmann M
    Rev Endocr Metab Disord; 2015 Sep; 16(3):177-98. PubMed ID: 26296373
    [TBL] [Abstract][Full Text] [Related]  

  • 33. In vivo hair growth promotion effects of ultra-high molecular weight poly-γ-glutamic acid from Bacillus subtilis (Chungkookjang).
    Choi JC; Uyama H; Lee CH; Sung MH
    J Microbiol Biotechnol; 2015 Mar; 25(3):407-12. PubMed ID: 25502822
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Relative Efficacy of Minoxidil and the 5-α Reductase Inhibitors in Androgenetic Alopecia Treatment of Male Patients: A Network Meta-analysis.
    Gupta AK; Venkataraman M; Talukder M; Bamimore MA
    JAMA Dermatol; 2022 Mar; 158(3):266-274. PubMed ID: 35107565
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The clinical applications of five-alpha reductase inhibitors.
    Loughlin KR
    Can J Urol; 2021 Apr; 28(2):10584-10588. PubMed ID: 33872554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of dutasteride 0.5 mg/d in men with androgenetic alopecia recalcitrant to finasteride.
    Jung JY; Yeon JH; Choi JW; Kwon SH; Kim BJ; Youn SW; Park KC; Huh CH
    Int J Dermatol; 2014 Nov; 53(11):1351-7. PubMed ID: 24898559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. 5-alpha-reductase inhibitor treatment for frontal fibrosing alopecia: an evidence-based treatment update.
    Murad A; Bergfeld W
    J Eur Acad Dermatol Venereol; 2018 Aug; 32(8):1385-1390. PubMed ID: 29524253
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transdermal finasteride delivery via powder-carrying microneedles with a diffusion enhancer to treat androgenetic alopecia.
    Kim S; Eum J; Yang H; Jung H
    J Control Release; 2019 Dec; 316():1-11. PubMed ID: 31689460
    [TBL] [Abstract][Full Text] [Related]  

  • 39. 5α-reductase inhibition and hair growth promotion of some Thai plants traditionally used for hair treatment.
    Kumar N; Rungseevijitprapa W; Narkkhong NA; Suttajit M; Chaiyasut C
    J Ethnopharmacol; 2012 Feb; 139(3):765-71. PubMed ID: 22178180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Beneficial Effects of Human Umbilical Cord Blood Mononuclear Cells on Persistent Erectile Dysfunction After Treatment of 5-Alpha Reductase Inhibitor in Rats.
    Oztekin CV; Yilmaz-Oral D; Kaya-Sezginer E; Kirlangic OF; Ozen FZ; Ozdal B; Topcu HO; Gur S
    J Sex Med; 2021 May; 18(5):889-899. PubMed ID: 33785264
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.